Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

A Unified Resource for Tracking Anti-CRISPR Names.

Bondy-Denomy J, Davidson AR, Doudna JA, Fineran PC, Maxwell KL, Moineau S, Peng X, Sontheimer EJ, Wiedenheft B.

CRISPR J. 2018 Oct;1:304-305. doi: 10.1089/crispr.2018.0043. No abstract available.

PMID:
31021273
2.

Anti-CRISPR-mediated control of gene editing and synthetic circuits in eukaryotic cells.

Nakamura M, Srinivasan P, Chavez M, Carter MA, Dominguez AA, La Russa M, Lau MB, Abbott TR, Xu X, Zhao D, Gao Y, Kipniss NH, Smolke CD, Bondy-Denomy J, Qi LS.

Nat Commun. 2019 Jan 14;10(1):194. doi: 10.1038/s41467-018-08158-x.

3.

Temperature-Responsive Competitive Inhibition of CRISPR-Cas9.

Jiang F, Liu JJ, Osuna BA, Xu M, Berry JD, Rauch BJ, Nogales E, Bondy-Denomy J, Doudna JA.

Mol Cell. 2019 Feb 7;73(3):601-610.e5. doi: 10.1016/j.molcel.2018.11.016. Epub 2018 Dec 27.

PMID:
30595438
4.

Discovery of widespread type I and type V CRISPR-Cas inhibitors.

Marino ND, Zhang JY, Borges AL, Sousa AA, Leon LM, Rauch BJ, Walton RT, Berry JD, Joung JK, Kleinstiver BP, Bondy-Denomy J.

Science. 2018 Oct 12;362(6411):240-242. doi: 10.1126/science.aau5174. Epub 2018 Sep 6.

5.

Phage Morons Play an Important Role in Pseudomonas aeruginosa Phenotypes.

Tsao YF, Taylor VL, Kala S, Bondy-Denomy J, Khan AN, Bona D, Cattoir V, Lory S, Davidson AR, Maxwell KL.

J Bacteriol. 2018 Oct 23;200(22). pii: e00189-18. doi: 10.1128/JB.00189-18. Print 2018 Nov 15.

6.

Bacteriophage Cooperation Suppresses CRISPR-Cas3 and Cas9 Immunity.

Borges AL, Zhang JY, Rollins MF, Osuna BA, Wiedenheft B, Bondy-Denomy J.

Cell. 2018 Aug 9;174(4):917-925.e10. doi: 10.1016/j.cell.2018.06.013. Epub 2018 Jul 19.

PMID:
30033364
7.

Protein Inhibitors of CRISPR-Cas9.

Bondy-Denomy J.

ACS Chem Biol. 2018 Feb 16;13(2):417-423. doi: 10.1021/acschembio.7b00831. Epub 2018 Jan 17. Review.

8.

How bacteria control the CRISPR-Cas arsenal.

Leon LM, Mendoza SD, Bondy-Denomy J.

Curr Opin Microbiol. 2018 Apr;42:87-95. doi: 10.1016/j.mib.2017.11.005. Epub 2017 Nov 21. Review.

9.

Pseudomonas aeruginosa defends against phages through type IV pilus glycosylation.

Harvey H, Bondy-Denomy J, Marquis H, Sztanko KM, Davidson AR, Burrows LL.

Nat Microbiol. 2018 Jan;3(1):47-52. doi: 10.1038/s41564-017-0061-y. Epub 2017 Nov 13.

PMID:
29133883
10.

The Discovery, Mechanisms, and Evolutionary Impact of Anti-CRISPRs.

Borges AL, Davidson AR, Bondy-Denomy J.

Annu Rev Virol. 2017 Sep 29;4(1):37-59. doi: 10.1146/annurev-virology-101416-041616. Epub 2017 Jul 27. Review.

11.

Disabling Cas9 by an anti-CRISPR DNA mimic.

Shin J, Jiang F, Liu JJ, Bray NL, Rauch BJ, Baik SH, Nogales E, Bondy-Denomy J, Corn JE, Doudna JA.

Sci Adv. 2017 Jul 12;3(7):e1701620. doi: 10.1126/sciadv.1701620. eCollection 2017 Jul.

12.

Cas1 and the Csy complex are opposing regulators of Cas2/3 nuclease activity.

Rollins MF, Chowdhury S, Carter J, Golden SM, Wilkinson RA, Bondy-Denomy J, Lander GC, Wiedenheft B.

Proc Natl Acad Sci U S A. 2017 Jun 27;114(26):E5113-E5121. doi: 10.1073/pnas.1616395114. Epub 2017 Apr 24.

13.

Structure Reveals Mechanisms of Viral Suppressors that Intercept a CRISPR RNA-Guided Surveillance Complex.

Chowdhury S, Carter J, Rollins MF, Golden SM, Jackson RN, Hoffmann C, Nosaka L, Bondy-Denomy J, Maxwell KL, Davidson AR, Fischer ER, Lander GC, Wiedenheft B.

Cell. 2017 Mar 23;169(1):47-57.e11. doi: 10.1016/j.cell.2017.03.012.

14.

CRISPR control of virulence in Pseudomonas aeruginosa.

Wiedenheft B, Bondy-Denomy J.

Cell Res. 2017 Feb;27(2):163-164. doi: 10.1038/cr.2017.6. Epub 2017 Jan 13.

15.

Inhibition of CRISPR-Cas9 with Bacteriophage Proteins.

Rauch BJ, Silvis MR, Hultquist JF, Waters CS, McGregor MJ, Krogan NJ, Bondy-Denomy J.

Cell. 2017 Jan 12;168(1-2):150-158.e10. doi: 10.1016/j.cell.2016.12.009. Epub 2016 Dec 29.

16.

Quorum sensing controls the Pseudomonas aeruginosa CRISPR-Cas adaptive immune system.

Høyland-Kroghsbo NM, Paczkowski J, Mukherjee S, Broniewski J, Westra E, Bondy-Denomy J, Bassler BL.

Proc Natl Acad Sci U S A. 2017 Jan 3;114(1):131-135. doi: 10.1073/pnas.1617415113. Epub 2016 Nov 14.

17.

The solution structure of an anti-CRISPR protein.

Maxwell KL, Garcia B, Bondy-Denomy J, Bona D, Hidalgo-Reyes Y, Davidson AR.

Nat Commun. 2016 Oct 11;7:13134. doi: 10.1038/ncomms13134.

18.

Prophages mediate defense against phage infection through diverse mechanisms.

Bondy-Denomy J, Qian J, Westra ER, Buckling A, Guttman DS, Davidson AR, Maxwell KL.

ISME J. 2016 Dec;10(12):2854-2866. doi: 10.1038/ismej.2016.79. Epub 2016 Jun 3.

19.

The diversity-generating benefits of a prokaryotic adaptive immune system.

van Houte S, Ekroth AK, Broniewski JM, Chabas H, Ashby B, Bondy-Denomy J, Gandon S, Boots M, Paterson S, Buckling A, Westra ER.

Nature. 2016 Apr 21;532(7599):385-8. doi: 10.1038/nature17436. Epub 2016 Apr 13.

20.

Active and adaptive Legionella CRISPR-Cas reveals a recurrent challenge to the pathogen.

Rao C, Guyard C, Pelaz C, Wasserscheid J, Bondy-Denomy J, Dewar K, Ensminger AW.

Cell Microbiol. 2016 Oct;18(10):1319-38. doi: 10.1111/cmi.12586. Epub 2016 Mar 31.

21.

Foreign DNA acquisition by the I-F CRISPR-Cas system requires all components of the interference machinery.

Vorontsova D, Datsenko KA, Medvedeva S, Bondy-Denomy J, Savitskaya EE, Pougach K, Logacheva M, Wiedenheft B, Davidson AR, Severinov K, Semenova E.

Nucleic Acids Res. 2015 Dec 15;43(22):10848-60. doi: 10.1093/nar/gkv1261. Epub 2015 Nov 19.

22.

Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins.

Bondy-Denomy J, Garcia B, Strum S, Du M, Rollins MF, Hidalgo-Reyes Y, Wiedenheft B, Maxwell KL, Davidson AR.

Nature. 2015 Oct 1;526(7571):136-9. doi: 10.1038/nature15254. Epub 2015 Sep 23.

23.

Parasite Exposure Drives Selective Evolution of Constitutive versus Inducible Defense.

Westra ER, van Houte S, Oyesiku-Blakemore S, Makin B, Broniewski JM, Best A, Bondy-Denomy J, Davidson A, Boots M, Buckling A.

Curr Biol. 2015 Apr 20;25(8):1043-9. doi: 10.1016/j.cub.2015.01.065. Epub 2015 Mar 12.

24.

A new group of phage anti-CRISPR genes inhibits the type I-E CRISPR-Cas system of Pseudomonas aeruginosa.

Pawluk A, Bondy-Denomy J, Cheung VH, Maxwell KL, Davidson AR.

MBio. 2014 Apr 15;5(2):e00896. doi: 10.1128/mBio.00896-14.

25.

When a virus is not a parasite: the beneficial effects of prophages on bacterial fitness.

Bondy-Denomy J, Davidson AR.

J Microbiol. 2014 Mar;52(3):235-42. doi: 10.1007/s12275-014-4083-3. Epub 2014 Mar 1. Review.

PMID:
24585054
26.

To acquire or resist: the complex biological effects of CRISPR-Cas systems.

Bondy-Denomy J, Davidson AR.

Trends Microbiol. 2014 Apr;22(4):218-25. doi: 10.1016/j.tim.2014.01.007. Epub 2014 Feb 26. Review.

PMID:
24582529
27.

Efficacy of bacteriophage treatment on Pseudomonas aeruginosa biofilms.

Phee A, Bondy-Denomy J, Kishen A, Basrani B, Azarpazhooh A, Maxwell K.

J Endod. 2013 Mar;39(3):364-9. doi: 10.1016/j.joen.2012.10.023. Epub 2012 Nov 28.

PMID:
23402508
28.

Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system.

Bondy-Denomy J, Pawluk A, Maxwell KL, Davidson AR.

Nature. 2013 Jan 17;493(7432):429-32. doi: 10.1038/nature11723. Epub 2012 Dec 16.

29.

The CRISPR/Cas adaptive immune system of Pseudomonas aeruginosa mediates resistance to naturally occurring and engineered phages.

Cady KC, Bondy-Denomy J, Heussler GE, Davidson AR, O'Toole GA.

J Bacteriol. 2012 Nov;194(21):5728-38. doi: 10.1128/JB.01184-12. Epub 2012 Aug 10.

30.

Myxoma virus oncolysis of primary and metastatic B16F10 mouse tumors in vivo.

Stanford MM, Shaban M, Barrett JW, Werden SJ, Gilbert PA, Bondy-Denomy J, Mackenzie L, Graham KC, Chambers AF, McFadden G.

Mol Ther. 2008 Jan;16(1):52-9. Epub 2007 Nov 13.

Supplemental Content

Loading ...
Support Center